Front Desk: 469-391-0070

Abciximab Medication: Uses, Dosage, Side Effects & Guidelines
Summary of Key Points
Abciximab is a medication used to prevent blood clots in patients with certain heart conditions, particularly during procedures like angioplasty. It works by inhibiting platelets, which are blood cells responsible for clot formation. Abciximab is commonly prescribed for patients with acute coronary syndrome or those undergoing percutaneous coronary intervention (PCI). Always consult your healthcare provider before starting or adjusting any medication.
Names of Medication
US Brand Name: ReoPro
Generic Name: Abciximab
The generic name refers to the active ingredient in the medication, while the brand name is assigned by the manufacturer. In this case, Abciximab is the generic name.
Pharmacologic Category
Glycoprotein IIb/IIIa Inhibitors
Antiplatelet Agents
Abciximab Dosage
Abciximab is used to manage various heart-related conditions. The dosage will vary depending on the specific condition being treated. Always follow your doctor’s instructions and consult them before making any changes to your medication. You can also schedule a telemedicine appointment with one of our providers for personalized guidance.
Acute Coronary Syndrome (ACS)
Initial Dose: 0.25 mg/kg IV bolus (a single dose injected into a vein).
Maintenance Dose: Followed by a continuous IV infusion of 0.125 mcg/kg/min for 12 hours.
Unstable Angina
Initial Dose: 0.25 mg/kg IV bolus.
Maintenance Dose: Continuous IV infusion at 0.125 mcg/kg/min for 12 hours.
Myocardial Infarction (Heart Attack)
Initial Dose: 0.25 mg/kg IV bolus.
Maintenance Dose: Continuous IV infusion at 0.125 mcg/kg/min for 12 hours.
Percutaneous Coronary Intervention (PCI)
Initial Dose: 0.25 mg/kg IV bolus 10-60 minutes before the procedure.
Maintenance Dose: Continuous IV infusion at 0.125 mcg/kg/min for 12 hours after the procedure.
Coronary Artery Disease (CAD)
Initial Dose: 0.25 mg/kg IV bolus.
Maintenance Dose: Continuous IV infusion at 0.125 mcg/kg/min for 12 hours.
Thrombosis
Initial Dose: 0.25 mg/kg IV bolus.
Maintenance Dose: Continuous IV infusion at 0.125 mcg/kg/min for 12 hours.
Ischemic Heart Disease
Initial Dose: 0.25 mg/kg IV bolus.
Maintenance Dose: Continuous IV infusion at 0.125 mcg/kg/min for 12 hours.
Atherosclerosis
Initial Dose: 0.25 mg/kg IV bolus.
Maintenance Dose: Continuous IV infusion at 0.125 mcg/kg/min for 12 hours.
Stroke
Initial Dose: 0.25 mg/kg IV bolus.
Maintenance Dose: Continuous IV infusion at 0.125 mcg/kg/min for 12 hours.
Dosage Forms and Strengths
Injection, solution: 2 mg/mL in a 5 mL vial
Abciximab Administration Guidelines
Abciximab is administered through an intravenous (IV) line, typically in a hospital or clinical setting. It is given as a bolus (a single, large dose) followed by a continuous infusion. Your healthcare provider will closely monitor you during administration to ensure the medication is working effectively and to watch for any potential side effects. Do not attempt to self-administer this medication. If you have any concerns, speak with your doctor or schedule a telemedicine appointment with one of our providers.
Abciximab Side Effects and Adverse Reactions
Like all medications, Abciximab can cause side effects. Some are more common than others, and some may be serious. If you experience any side effects, contact your healthcare provider immediately. You can also reach out to one of our telemedicine providers for advice.
- Bleeding (Common): Abciximab increases the risk of bleeding, particularly at the injection site or during procedures.
- Low Platelet Count (Thrombocytopenia) (Common): This can result in increased bleeding or bruising.
- Nausea (Common): Some patients may experience nausea during or after the infusion.
- Hypotension (Low Blood Pressure) (Less Common): Abciximab may cause a drop in blood pressure, which can lead to dizziness or lightheadedness.
- Allergic Reactions (Rare): Some patients may experience an allergic reaction, including rash, itching, or difficulty breathing.
Abciximab Contraindications
A contraindication is a specific situation or condition where a particular treatment or medication should not be used because it may cause harm. When a medication is contraindicated, the risks of taking it far outweigh any potential benefits. Below are the contraindications for taking Abciximab:
- Active internal bleeding: Abciximab can increase the risk of bleeding, so it should not be used in patients currently experiencing internal bleeding, as it could worsen the condition.
- Recent surgery or trauma: If you have had surgery or a significant injury within the past 6 weeks, Abciximab may increase the risk of excessive bleeding during recovery.
- Severe uncontrolled hypertension (high blood pressure): High blood pressure can increase the risk of bleeding in the brain (hemorrhagic stroke) when using Abciximab.
- History of stroke within the last two years: Patients who have had a stroke recently are at a higher risk of bleeding complications, especially in the brain, when taking Abciximab.
- Thrombocytopenia (low platelet count): Abciximab works by preventing platelets from clumping together, so if your platelet count is already low, this medication could lead to dangerous bleeding.
- Hypersensitivity to Abciximab or similar medications: If you have had an allergic reaction to Abciximab or similar drugs in the past, taking it again could cause a severe allergic reaction.
Drug to Drug Interactions with Abciximab
Like many medications, Abciximab can interact with other drugs, potentially increasing the risk of side effects or reducing its effectiveness. Below are some common medications that may interact with Abciximab:
Warfarin (Coumadin): Both Warfarin and Abciximab increase the risk of bleeding. Taking them together significantly raises the likelihood of serious bleeding complications.
Heparin: Heparin is another blood thinner, and using it alongside Abciximab can further elevate the risk of bleeding.
Aspirin (Bayer, Ecotrin): Aspirin is often used to prevent blood clots, but when combined with Abciximab, the risk of bleeding becomes higher.
Clopidogrel (Plavix): Like Abciximab, Clopidogrel prevents platelets from clumping together. Using them together can increase the risk of bleeding.
Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Medications such as Ibuprofen (Advil, Motrin) and Naproxen (Aleve) can also raise the risk of bleeding when taken with Abciximab.
Abciximab in Pregnancy: Is It Safe?
Is it safe to take Abciximab during pregnancy?
There is limited information on the use of Abciximab during pregnancy. While animal studies have not shown direct harm to the fetus, no well-controlled studies have been conducted in pregnant women. Since Abciximab affects blood clotting, it may increase the risk of bleeding, particularly during labor and delivery. If you are pregnant or planning to become pregnant, it is important to discuss the potential risks and benefits of taking Abciximab with your healthcare provider. Our telemedicine providers are available to help you make an informed decision.
Abciximab and Breastfeeding: What You Need to Know
Is it safe to take Abciximab while breastfeeding?
It is not known whether Abciximab passes into breast milk. Due to the potential for serious side effects in a nursing infant, it is generally recommended to avoid breastfeeding while taking Abciximab. Alternatively, you can discuss other treatment options with your healthcare provider. If you are breastfeeding and need to take Abciximab, consult with one of our telemedicine providers to explore your options.
Estimated Cost of Abciximab Medication
The cost of Abciximab can vary depending on your location and the pharmacy you use. Without insurance, the estimated cost for a 30-day supply of Abciximab using a GoodRx coupon ranges from approximately $1,200 to $1,500. Prices may fluctuate, so it is always a good idea to check with your pharmacy for the most accurate pricing.
Possible Alternatives to Abciximab
If Abciximab is not suitable for you, there are alternative treatments and lifestyle changes that may help manage the conditions it is used to treat. Always discuss these alternatives with your healthcare provider before making any changes to your treatment plan. Our telemedicine providers are available to guide you through these options.
- Acute coronary syndrome: Alternatives include medications like Clopidogrel (Plavix) or Prasugrel (Effient), along with lifestyle changes such as quitting smoking, adopting a heart-healthy diet, and engaging in regular exercise.
- Unstable angina: Treatment options may include beta-blockers, nitrates, or calcium channel blockers. Lifestyle changes like stress management and increased physical activity can also be beneficial.
- Myocardial infarction (heart attack): Medications such as Aspirin, beta-blockers, and ACE inhibitors may be used. Cardiac rehabilitation and lifestyle changes, such as maintaining a healthy weight and controlling blood pressure, are also important.
- Percutaneous coronary intervention (PCI): Alternatives include other antiplatelet medications like Ticagrelor (Brilinta) or Clopidogrel (Plavix). Discuss with your provider which option is best for you.
- Coronary artery disease: Statins, beta-blockers, and ACE inhibitors are commonly used. Lifestyle changes such as reducing cholesterol intake and increasing physical activity can also be beneficial.
- Thrombosis: Anticoagulants like Warfarin (Coumadin) or newer agents like Apixaban (Eliquis) may be alternatives. Staying active and avoiding long periods of immobility can also help prevent blood clots.
- Ischemic heart disease: Medications like nitrates, beta-blockers, and calcium channel blockers are often used. A heart-healthy diet and regular exercise can also improve outcomes.
- Atherosclerosis: Statins and other cholesterol-lowering medications may be prescribed. Lifestyle changes such as quitting smoking, eating a diet rich in fruits and vegetables, and regular exercise are key to managing this condition.
- Heart attack: In addition to medications like Aspirin and beta-blockers, lifestyle changes such as maintaining a healthy weight, controlling blood pressure, and participating in cardiac rehabilitation can help reduce the risk of future heart attacks.
- Stroke: Antiplatelet medications like Clopidogrel (Plavix) or anticoagulants like Warfarin (Coumadin) may be used. Managing risk factors like high blood pressure, diabetes, and high cholesterol through lifestyle changes is also crucial.
Recent Updates on Abciximab Research
Recent studies have focused on optimizing the use of Abciximab in various cardiovascular procedures, particularly in patients undergoing percutaneous coronary intervention (PCI). Research is ongoing to determine whether lower doses of Abciximab can be used effectively to reduce the risk of bleeding while still providing protection against blood clots. Additionally, studies are exploring the use of Abciximab in combination with newer antiplatelet agents to improve outcomes for patients with acute coronary syndrome and other heart conditions. As new findings emerge, it is important to discuss with your healthcare provider whether these developments may impact your treatment plan. Our telemedicine providers are available to help you stay informed about the latest research and how it may affect your care.